Systemisk lupus erythematosus, SLE
Senast uppdaterad: Senast reviderad:
Sakkunnig:Anna Nager
Definition:
Systemisk lupus erythematosus (SLE) är en kronisk, recidiverande, inflammatorisk bindvävssjukdom med symtom från många organsystem.
Förekomst:
I Sverige är incidensen 2–3 per 100 000 och år.
Symtom:
Vanligast är utslag och ledbesvär, men man kan få symtom från njurar, luftvägar, blod, rörelseorganen och nervsystemet.
Kliniska fynd:
Kliniska fynd från många organ.
Diagnostik:
Typiska laboratoriefynd är positiv ANA, anti-dsDNA och anemi. I aktiv fas förhöjd SR.
Behandling:
hydroxiklorokin, kortison, olika cytostatika och biologiska läkemedel.
- Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16. PMID: 30448290 PubMed
- Reumatikerförbundet: SLE reumatiker.se
- Barber MRW, Drenkard C, Falasinnu T et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021 Sep;17(9):515-532. doi: 10.1038/s41584-021-00668-1. Epub 2021 Aug 3. Erratum in: Nat Rev Rheumatol. 2021 Sep 1;: PMID: 34345022 PubMed
- Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81-ITC96. PMID: 32479157 PubMed
- Charras A, Smith E, Hedrich CM. Systemic Lupus Erythematosus in Children and Young People. Curr Rheumatol Rep. 2021 Feb 10;23(3):20. doi: 10.1007/s11926-021-00985-0. PMID: 33569643 PubMed
- Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33. PMID: 14561795 PubMed
- Generali E, Ceribelli A, Stazi MA, Selmi C. Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun. 2017 Sep;83:51-61. doi: 10.1016/j.jaut.2017.04.005. Epub 2017 Apr 18. PMID: 28431796 PubMed
- Ghodke-Puranik Y, Niewold TB. Immunogenetics of systemic lupus erythematosus: A comprehensive review. J Autoimmun. 2015 Nov;64:125-36. doi: 10.1016/j.jaut.2015.08.004. Epub 2015 Aug 29. PMID: 26324017 PubMed
- Aringer M, Brinks R, Dörner T, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis 2021. pmid:33568386 PubMed
- Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011;164(6):1335-1341. doi:10.1111/j.1365-2133.2011.10272.x.PMID: 21574972 PubMed
- Rubin RL. Drug-induced lupus. Expert Opin Drug Saf 2015; 14: 361-78. pmid:25554102 PubMed
- Akaogi J, Barker T, Kuroda Y et al. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev 2006; 5: 429-35. pmid:16890899 PubMed
- Gluhovschi C, Gluhovschi G, Petrica L, et al. Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma. J Immunol Res 2015. pmid:26090485 PubMed
- Levy DM, Klein-Gitelman M, TePas E. Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis. UpToDate. Last updated Jun 29, 2020. www.uptodate.com
- Skorpen CG, Lydersen S, Gilboe IM et al. Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study. Ann Rheum Dis 2018; 77: 264-69. pmid:29092851 PubMed
- Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol 2012; 8: 439-53. pmid:22882219 PubMed
- Götestam Skorpen C, Lydersen S, Gilboe IM et al. Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2017; 69: 1201-08. pmid:27696790 PubMed
- Vu Lam N-C, Ghetu MV, Bieniek ML. Systemic lupus erythematosus: Primary care approach to diagnosis and management. Am Fam Physician 2016 Aug 15; 94(4): 284-94. pmid:27548593 PubMed
- Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity (2009) 42:257–9. DOI:10.1080/08916930902827918. PMID: 19811269 PubMed
- Buyon JP, Kim MY, Guerra MM, et al. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med 2015; 163: 153-63. pmid:26098843 PubMed
- Yelnik CM, Laskin CA, Porter TF et al. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 2016; 3(1): epub. pmid:26835148 PubMed
- Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61–73. pmid:19932376 PubMed
- Nationellt kliniskt kunskapsstöd. SLE. Hämtad 2022-11-15. nationelltklinisktkunskapsstod.se
- Riktlinjer för behandling av systemisk lupus erytematosus (SLE) Svensk Reumatologisk Förening. Hämtad 2022-12-22 riktlinjer.svenskreumatologi.se
- Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev 2009; 8: 456-61. pmid:19167524 PubMed
- D'Cruz DP. Systemic lupus erythematosus. BMJ 2006; 332: 890-4. PubMed
- Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20-8. PubMed
- Barsalou J, Costedoat-Chalumeau N, Berhanu A et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus. Ann Rheum Dis 2018; 77: 1742-49. pmid:30297329 PubMed
- Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126: 76-82. pmid:22626746 PubMed
- Gleicher N, Elkayam U. Preventing congenital heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies. A review of published literature and registered clinical trials. Autoimmune Rev 2013;12:1039-45. PMID: 23684701 PubMed
- Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D’Cruz DP. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) 2004; 43: 1383-5. PubMed
- Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus. 2014 Mar;23(3):225-35. doi: 10.1177/0961203313519159. [url]http://dx.doi.org/10.1177/0961203313519159[/url] PMID: 24399812 PubMed
- Antikonception - behandlingsrekommendation. Läkemedelsverket 2014 www.lakemedelsverket.se
- Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66: 608-16. pmid:24106157 PubMed
- Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet